Patients With ALS Do Not Benefit From Growth Hormone
Nov 25th 2008Drug InformationMultiple Sclerosis
A growth hormone that had shown some promise for treating people with amyotrophic lateral sclerosis (ALS) showed no benefit in a new study published in the November 25, 2008, issue of Neurology, the medical journal of the American Academy of Neurology. Two previous, shorter studies using growth hormone insulin-like growth factor-1, or IGF-1, to treat ALS had conflicting results.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
